Lv1
32 积分 2024-04-19 加入
Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action
6天前
已完结
A Better IgE Trap to Control Urticaria
7天前
已完结
Animal models of obesity and diabetes mellitus
11天前
已完结
Mechanistic Pharmacokinetic/Target Engagement/Pharmacodynamic (PK/TE/PD) Modeling in Deciphering Interplay Between a Monoclonal Antibody and Its Soluble Target in Cynomolgus Monkeys
14天前
已完结
Amino acids are sensitive glucagon receptor‐specific biomarkers for glucagon‐like peptide‐1 receptor/glucagon receptor dual agonists
1个月前
已完结
Development of Assay for Determining Free IgE Levels in Serum from Patients Treated with Omalizumab
1个月前
已完结
Molecular mechanism of IgE-mediated FcεRI activation
1个月前
已完结
Biologics: An Update and Challenge of Their Pharmacokinetics
2个月前
已完结
Structure and dynamics of IgE–receptor interactions: FcεRI and CD23/FcεRII
2个月前
已完结
Why does GLP‐1 agonist combined with GIP and/or GCG agonist have greater weight loss effect than GLP‐1 agonist alone in obese adults without type 2 diabetes?
2个月前
已完结
皖公网安备34019202002308
